Pfizer felony & record $2.3B fine: Will they talk about this at the Pfizer-funded journalism training workshop?

Pfizer Inc. has agreed to pay $2.3 billion to settle charges that it illegally marketed the pain drug Bextra and three other medicines for uses that weren't approved by the Food and Drug Administration, Dow Jones Newswire reports. More from the story:

The Justice Department said the agreement was the largest health-care fraud settlement in the department's history.

The department said that, as part of the settlement, Pfizer subsidiary Pharmacia & Upjohn Co. agreed to plead guilty to a felony violation for misbranding Bextra.

The department said Pfizer promoted Bextra for several uses and dosages that the FDA specifically declined to approve because of safety concerns.

Pfizer also improperly promoted the anti-psychotic drug Geodon, the antibiotic drug Zyvox and the anti-epileptic drug Lyrica, the department said.

Hmmm. Wonder if the 16 journalists who accepted Pfizer-funded, all-expenses paid trips to DC to the National Press Foundation September 13-16 will get a workshop on off-label marketing techniques?

Similarly, I wonder if journalists at the Society of Professional Journalists national conference in Indianapolis last week who schmoozed at the Lilly headquarters for "networking" or "professional development" heard anything about Lilly's $1.4 billion fine this year for off-label promotion of Zyprexa?

Wanna bet?

About this Entry

This page contains a single entry by Gary Schwitzer published on September 2, 2009 2:31 PM.

They have health insurance and they're still driven to debt was the previous entry in this blog.

At least Canadian radio seems interested in the state of US TV health journalism is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.



Wikio - Top of the Blogs - Health

Add to Technorati Favorites